| Active substance |
Nifedipine |
| Also known as |
Adalat |
| Blood pressure |
Reduces systolic and diastolic blood pressure |
| Chemical name |
Dimethyl 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylate |
| Dosage (medical) |
Typically 10 to 60 mg daily in divided doses for hypertension and angina |
| Dosage (sports) |
Not applicable |
| Effects |
Reduction in arterial pressure, increased oxygen delivery to the myocardium |
| Formula |
C17H18N2O6 |
| Half-life |
2 to 5 hours |
| Hepatotoxicity |
Low risk |
| Lab Test |
Not specific for monitoring nifedipine |
| Main action |
Lowers blood pressure by relaxing blood vessels and decreasing heart workload |
| Side effects |
Headache, flushing, dizziness, peripheral edema, palpitations |
| Storage conditions |
Store at room temperature, protect from light and moisture |
| Strength |
30mg |
| Substance class |
Calcium channel blocker |
| Trade name |
Adalat, Procardia |
| Use in sports |
Not typically used in sports |
| Water Retention |
Minimal |
| Manufacturer |
J.B. Chemicals & Pharmaceuticals Ltd. |
| Packing |
10 tabs/blister |
